Company intelligence / Profile preview

Sionex

Bedford, Massachusetts, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Sionex Corporation was a technology company specializing in the development of High-Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS) and micro-Differential Mobility Spectrometry (microDMx) sensors. The company's miniaturized sensor chips were designed for the rapid detection and identification of trace levels of chemical and biological compounds. Its technology found applications in homeland security, industrial process control, and medical diagnostics, particularly in breath analysis and biomarker detection. In 2013, the assets of Sionex were acquired by Thermo Fisher Scientific to enhance their analytical instrument portfolio.

Therapeutic areas: Other
Modalities: Device
Industry: Metabolite Diagnostics

Partnerships

Varian Medical Systems

Beyond the preview

Go deeper on Sionex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sionex.

Explore the full profile